Solventum CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
Solventum Corporation's 2025 annual report highlights significant net income growth driven by a major divestiture, alongside strategic acquisitions and a multi-year restructuring program.
NYSE
Solventum's 2024 10-K filing details its first year as an independent company, highlighting financial performance, strategic shifts post-spin-off from 3M, and navigating a complex regulatory environment.